SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-24-039115
Filing Date
2024-09-03
Accepted
2024-09-03 16:07:59
Documents
12

Document Format Files

Seq Description Document Type Size
1 S-3 akebiatherapeutics-sx3.htm S-3 525022
2 EX-FILING FEES exhibit107-sx3.htm EX-FILING FEES 67632
3 EX-1.2 exhibit12-sx3.htm EX-1.2 307445
4 EX-4.7 exhibit47-sx3.htm EX-4.7 418758
5 EX-4.8 exhibit48-sx3.htm EX-4.8 449426
6 EX-4.9 exhibit49-sx3.htm EX-4.9 51178
7 EX-4.10 exhibit410-sx3.htm EX-4.10 50771
8 EX-5.1 exhibit51-sx3.htm EX-5.1 42686
9 EX-23.1 exhibit231-sx3.htm EX-23.1 2444
10 akebia.jpg GRAPHIC 53812
11 exhibit51.jpg GRAPHIC 32698
12 prospectuscover.jpg GRAPHIC 57136
  Complete submission text file 0001628280-24-039115.txt   2106026
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-281903 | Film No.: 241274098
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)